Complete screening of the CFTR gene in Argentine cystic fibrosis patients

Clinical Genetics

Volumn 61, Issue 3, 2002, Pages 207-213

  Visich, A ^a   Zielenski, J ^b   Castanos C ^a   Diez, G ^c   Grenoville, M ^a   Segal, E ^c   Barreiro, C ^a   Tsui, L C ^b   Chertkoff, Lilien P ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Hospital de Ninos Sor Maria Ludovica   (Argentina)

Author keywords

Argentine population; CFTR mutations; Cystic fibrosis

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ARGENTINA; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DNA POLYMORPHISM; DNA SEQUENCE; ETHNOLOGY; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC SCREENING; HETERODUPLEX ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL;

ARGENTINA; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC SCREENING; HUMANS; MUTATION; POLYMORPHISM, GENETIC;

ARGENTINA (FISH);

EID: 0036524147     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.610307.x     Document Type: Article

References (27)

1. Boat TF, Welsh MJ, Beadet AL. Cystic fibrosis. In: Scriver CR, Beadet AL, Sly WS, Valle D, eds. The metabolic basic inherited disease. New York, NY. McGraw-Hill, 1989: 2649-2680.
2. Borrajo GJC, Adam MM, Castillo PI, Lanz MH, Di Carlo CM, Gómez FR, et al. Screening neonatal de fibrosis quística. Experiencia en más de 100.000 neonatos estudiados. In: Proceedings of the IX Congreso Latinoamericano de Fibrosis Quística, Buenos Aires: Sociedad Argentina de Pediatría, 1999: 83.
3. Cystic Fibrosis Genetic Analysis Consortium (CFGAC). Update list March 2000. In: Cystic Fibrosis mutation database (www.genet.sickkids.on.ca/oftr/).
4. Cystic Fibrosis Genetic Analysis Consortium (CFGAC). Population variation of common cystic fibrosis mutations. Hum Mutat 1994: 4: 167-177.
5. Chertkoff L, Visich A, Bienvenu T, Grenoville M, Segal E, Carniglia L, et al. Spectrum of CFTR mutations in argentine cystic fibrosis patients. Clin Genet 1997: 51: 43-47.
6. Bienvenu T, Chertkoff L, Beldjord C, Segal E, Carniglia L, Barreiro C, et al. Identification of three novel mutations in the cystic fibrosis transmembrane conductance regulator gene in Argentinian CF patients. Hum Mutat 1996: 7: 376-377.
7. Zielenski J, Aznarez I, Onay T, Tzountzouris J, Markiewicz D, et al. CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel. In: Skach W, ed. Cystic fibrosis methods and protocols - methods in molecular medicine series. Totowa, NJ: The Humana Press, (in press).
8. Gibson L, Cooke R. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis. Pediatrics 1959: 3: 545.
9. van der Kamer JH, ten Bokkel Hiunink H, Weyers HA. Rapid method for the determination of fat in faeces. J Biol Chem 1949: 177: 347-355.
10. Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, et al. A novel mutation in the cystic fibrosis gene in patient with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994: 331: 974-980.
11. Casals T, Ramos MD, Giménez J, Larriba S, Nunes V, Estivill X. High heterogeneity for cystic fibrosis Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 1997: 101: 365-370.
12. Bonizzato A, Bisceglia L, Mariggo C, Nicolis E, Bombieri C, Castellani C, et al. Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from North-Eastern Italy: identification of 90% of the mutations. Hum Genet 1995: 95: 397-402.
13. Orozco L, Zielenski J, Tsui L-C, Chávez M, Lezana JL, Saldaña Y, et al. Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1098C, 846delT, P750L, 4160insGGGG and 297-IG→A). Hum Genet 2000: 106: 360-365.
14. Bernardino ALF, Ferri A, Passos-Bueno MR, Kim CEA, Nakaie CMA, Gómez CET, et al. Molecular analysis in Brazilian cystic fibrosis patients reveals five novel mutations. Genetic Testing 2000: 4: 69-74.
15. Luzardo G, Crispino B, Mimbacas A, Martínez L, Cardozo G. Análisis de las frecuencias de las mutaciones de fibrosis quística según criterios diagnósticos en una muestra de la población uruguaya. In: Proceedings of the IX Congreso Latinoamericano de Fibrosis Quística, Buenos Aires: Sociedad Argentina de Pediatra, 1999: 87.
16. Ríos J, Orellana O, Aspillaga M, Avendano I, Largo I, Riveros N. CFTR mutations in Chilean cystic fibrosis patients. Hum Genet 1994: 94: 291-294.
17. Gentile AS, Sauri L, Macri CN. Situación de la fibrosis quística en Argentina. In: Proceedings of the IX Congreso Latinoamericano de Fibrosis Quística, Buenos Aires: Sociedad Argentina de Pediatría, 1999: 73.
18. Palatnik M. Seroantropología argentina. Sangre 1966: 11: 395-412.
19. Macció GA, Elizalde D. La población no Nativa de la Argentina. Buenos Aires: Instituto Nacional de Estadísticas y Censos, 1996.
20. Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, et al. Association of nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 1992: 50: 222-228.
21. Augarten A, Kerem B-S, Yahav Y, Noiman S, Rivlin J, Blau H, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+10kbC→T mutation. Lancet 1993: 342: 25-26.
22. Demographic Yearbook. Special topic: ethnic and economic characteristics. New York, NY: Statistical office of the United Nations, 1956: 272-274.
23. Kanavakis E, Tzetis M, Antoniadi T, Traeger-Synodinos J, Doudounakis S, Adam G, et al. Mutation analysis of 10 exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation. Hum Genet 1995: 96: 364-366.
24. Goldman A, Labrum R, Claustres M, Desgeorges M, Guittard C, Wallace A, et al. The molecular basis of cystic fibrosis in South Africa. Clin Genet 2001: 59: 37-41.
25. Onay T, Zielenski J, Topalogu O, Gokgoz N, Kayserili H, Apak MY, et al. Cystic fibrosis mutations and associated haplotypes in Turkish cystic fibrosis patients. Hum Biol 2001: 73: 191-203.
26. Nollau P, Wagener C. Methods for detection of point mutations: performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques. Clin Chem 1997: 43: 1114-1128.
27. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998: 132: 589-595.